Status:
COMPLETED
Potential Role of Ocular Surface Microbiome in Dry Eye: Microbial Interactions and Symptom Alleviation
Lead Sponsor:
Hallym University Kangnam Sacred Heart Hospital
Conditions:
Dry Eye Syndrome (DES)
Eligibility:
All Genders
19-90 years
Phase:
NA
Brief Summary
Study design and sample collection This study is randomized, double-blind, and prospective trial. The inclusion criteria were as follows: patients aged 19 years or older with symptoms of dry eye syndr...
Eligibility Criteria
Inclusion
- patients aged 19 years or older
- with symptoms of dry eye syndrome.
Exclusion
- the use of topical ocular drops or systemic medication (such as systemic steroids, immunomodulators, and tetracyclines) that could influence study outcomes
- the presence of conjunctivitis, anterior blepharitis, Demodex infestation, parasitic eye infections, unresolved ocular trauma, healing disorders of the ocular surface (OS),
- a history of penetrating keratoplasty, contact lens use, or any ophthalmic surgical procedure within three months before baseline.
- a single functional eye, pregnant or breastfeeding women, and those at risk of pregnancy without contraception
Key Trial Info
Start Date :
January 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 28 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06936462
Start Date
January 20 2020
End Date
January 28 2024
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hallym University, Kangnam Sacred Heart Hospital
Seoul, Seoul, South Korea, 07441